Erdoğan Mehmet, Bozkurt Engin
Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Department of Cardiology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey.
Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Jan 23;28(1):205-208. doi: 10.5606/tgkdc.dergisi.2020.18613. eCollection 2020 Jan.
In recent years, indications and age range of patients who are eligible for transcatheter aortic valve replacement have been increasingly extended. The presence of a thrombus in the left atrial appendage is an exclusion criterion in many studies using transcatheter aortic valve replacement. An 86-year-old male patient was admitted with symptomatic severe aortic stenosis secondary to degeneration of a 22-mm bioprosthetic valve implanted 14 years ago. Transesophageal echocardiography revealed a thrombus in the left atrial appendage and it was confirmed by contrast-enhanced computed tomography. The balloon-expandable valve was successfully implanted into the degenerated aortic bioprosthesis. In conclusion, we aimed to show that valve-in-valve transcatheter aortic valve replacement can be performed in a patient with thrombus in the left atrial appendage.
近年来,适合经导管主动脉瓣置换术的患者的适应症和年龄范围不断扩大。在许多使用经导管主动脉瓣置换术的研究中,左心耳血栓的存在是一项排除标准。一名86岁男性患者因14年前植入的22毫米生物瓣膜退变继发症状性严重主动脉瓣狭窄入院。经食管超声心动图显示左心耳有血栓,对比增强计算机断层扫描证实了这一点。球囊扩张瓣膜成功植入退变的主动脉生物瓣膜中。总之,我们旨在表明,左心耳有血栓的患者也可以进行瓣中瓣经导管主动脉瓣置换术。